Sucandy, Iswanto
Rayman, Shlomi
Lai, Eric C.
Tang, Chung-Ngai
Chong, Yvette
Efanov, Mikhail
Fuks, David
Choi, Gi-Hong
Chong, Charing C.
Chiow, Adrian K. H.
Marino, Marco V.
Prieto, Mikel
Lee, Jae-Hoon
Kingham, T. Peter
D’Hondt, Mathieu
Troisi, Roberto I.
Choi, Sung Hoon
Sutcliffe, Robert P.
Cheung, Tan-To
Rotellar, Fernando
Park, James O.
Scatton, Olivier
Han, Ho-Seong
Pratschke, Johann
Wang, Xiaoying
Liu, Rong
Goh, Brian K. P. http://orcid.org/0000-0001-8218-4576
Chan, Chung-Yip
D’Silva, Mizelle
Schotte, Henri
De Meyere, Celine
Krenzien, Felix
Schmelzle, Moritz
Kadam, Prashant
Montalti, Roberto
Liu, Qu
Lee, Kit-Fai
Salimgereeva, Diana
Alikhanov, Ruslan
Lee, Lip Seng
Gastaca, Mikel
Jang, Jae Young
Lim, Chetana
Labadie, Kevin P.
,
Article History
Received: 11 May 2022
Accepted: 27 June 2022
First Online: 23 August 2022
Disclosure
: Dr Brian K. P. Goh has received travel grants and honorarium from Johnson and Johnson and Transmedic, the local distributor for the Da Vinci robot. Dr Marco V. Marino is a consultant for CAVA robotics LLC. Johann Pratschke reports a research grant from Intuitive Surgical Deutschland GmbH and personal fees or non-financial support from Johnson & Johnson, Medtronic, AFS Medical, Astellas, CHG Meridian, Chiesi, Falk Foundation, La Fource Group, Merck, Neovii, NOGGO, pharma-consult Peterson, and Promedicis. Moritz Schmelzle reports personal fees or other support outside of the submitted work from Merck, Bayer, ERBE, Amgen, Johnson & Johnson, Takeda, Olympus, Medtronic, Intuitive. Fernando Rotellar reports speaker fees and support outside the submitted work from Integra, Medtronic, Olympus, Corza, Sirtex and Johnson & Johnson. The remaining authors haved no conflicts of interest.